Cryofocus Medtech (Shanghai) Co (HKSE:06922) Price-to-Free-Cash-Flow : N/A (As of May. 01, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Price-to-Free-Cash-Flow?

As of today (2024-05-01), Cryofocus Medtech (Shanghai) Co's share price is HK$12.26. Cryofocus Medtech (Shanghai) Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-0.56. Hence, Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow or its related term are showing as below:

HKSE:06922's Price-to-Free-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 32.405
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Cryofocus Medtech (Shanghai) Co's Free Cash Flow per Share for the six months ended in Jun. 2023 was HK$-0.28. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was HK$-0.56.

Cryofocus Medtech (Shanghai) Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Price-to-Free-Cash-Flow Chart

Cryofocus Medtech (Shanghai) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Free-Cash-Flow

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow falls into.

Cryofocus Medtech (Shanghai) Co Price-to-Free-Cash-Flow Calculation

Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	12.26	/	-0.564
	=	N/A

Cryofocus Medtech (Shanghai) Co's Share Price of today is HK$12.26.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cryofocus Medtech (Shanghai) Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-0.56.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Cryofocus Medtech (Shanghai) Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120

Website

https://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines